Report Detail

In 2019, the market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs.

This report studies the global market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
This study presents the Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs sales volume, revenue, market share and growth rate for each key company, and also covers the breakdown data (sales, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

In global market, the following companies are covered:
GlaxoSmithKline Plc
Helsinn Group
Heron Therapeutics
Merck & Co Inc
Tesaro
...

Market Segment by Product Type
Corticosteroids
Serotonin Antagonists
Dopamine Antagonists
NK-1 Inhibitors
Cannabinoids
Motion Sickness Treatments
Anti-Anxiety Drugs
Other

Market Segment by Application
High Emetic Risk Intravenous Chemotherapy
Moderate Emetic Risk Intravenous Chemotherapy
Low and Minimal Emetic Risk Intravenous Chemotherapy
Other

Key Regions split in this report: breakdown data for each region.
United States
China
European Union
Rest of World (Japan, Korea, India and Southeast Asia)

The study objectives are:
To analyze and research the Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
To present the key Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs manufacturers, presenting the sales, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

In this study, the years considered to estimate the market size of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025


Table of Contents

    1 Report Overview

    • 1.1 Study Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Corticosteroids
      • 1.3.3 Serotonin Antagonists
      • 1.3.4 Dopamine Antagonists
      • 1.3.5 NK-1 Inhibitors
      • 1.3.6 Cannabinoids
      • 1.3.7 Motion Sickness Treatments
      • 1.3.8 Anti-Anxiety Drugs
      • 1.3.9 Other
    • 1.4 Market Segment by Application
      • 1.4.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Share by Application (2019-2025)
      • 1.4.2 High Emetic Risk Intravenous Chemotherapy
      • 1.4.3 Moderate Emetic Risk Intravenous Chemotherapy
      • 1.4.4 Low and Minimal Emetic Risk Intravenous Chemotherapy
      • 1.4.5 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Size
      • 2.1.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue 2014-2025
      • 2.1.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales 2014-2025
    • 2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Growth Rate by Regions
      • 2.2.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Regions 2014-2019
      • 2.2.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Regions 2014-2019
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers
      • 3.1.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Manufacturers 2014-2019
      • 3.1.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Manufacturers 2014-2019
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Manufacturers (2014-2019)
      • 3.2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Concentration Ratio (CR5 and HHI)
    • 3.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Manufacturers
    • 3.4 Key Manufacturers Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market
    • 3.6 Key Manufacturers Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Sales and Revenue for Each Type
      • 4.1.1 Corticosteroids Sales and Revenue (2014-2019)
      • 4.1.2 Serotonin Antagonists Sales and Revenue (2014-2019)
      • 4.1.3 Dopamine Antagonists Sales and Revenue (2014-2019)
      • 4.1.4 NK-1 Inhibitors Sales and Revenue (2014-2019)
      • 4.1.5 Cannabinoids Sales and Revenue (2014-2019)
      • 4.1.6 Motion Sickness Treatments Sales and Revenue (2014-2019)
      • 4.1.7 Anti-Anxiety Drugs Sales and Revenue (2014-2019)
      • 4.1.8 Other Sales and Revenue (2014-2019)
    • 4.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Market Share by Type
    • 4.3 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Market Share by Type
    • 4.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Application

    6 United States

    • 6.1 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company
    • 6.2 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Type
    • 6.3 United States Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Application

    7 European Union

    • 7.1 European Union Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company
    • 7.2 European Union Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Type
    • 7.3 European Union Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Application

    8 China

    • 8.1 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company
    • 8.2 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Type
    • 8.3 China Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Application

    9 Rest of World

    • 9.1 Rest of World Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Company
    • 9.2 Rest of World Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Type
    • 9.3 Rest of World Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Application
    • 9.4 Rest of World Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Breakdown Data by Countries
      • 9.4.1 Rest of World Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales by Countries
      • 9.4.2 Rest of World Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue by Countries
      • 9.4.3 Japan
      • 9.4.4 Korea
      • 9.4.5 India
      • 9.4.6 Southeast Asia

    10 Company Profiles

    • 10.1 GlaxoSmithKline Plc
      • 10.1.1 GlaxoSmithKline Plc Company Details
      • 10.1.2 Company Description and Business Overview
      • 10.1.3 Sales, Revenue and Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
      • 10.1.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
      • 10.1.5 GlaxoSmithKline Plc Recent Development
    • 10.2 Helsinn Group
      • 10.2.1 Helsinn Group Company Details
      • 10.2.2 Company Description and Business Overview
      • 10.2.3 Sales, Revenue and Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
      • 10.2.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
      • 10.2.5 Helsinn Group Recent Development
    • 10.3 Heron Therapeutics
      • 10.3.1 Heron Therapeutics Company Details
      • 10.3.2 Company Description and Business Overview
      • 10.3.3 Sales, Revenue and Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
      • 10.3.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
      • 10.3.5 Heron Therapeutics Recent Development
    • 10.4 Merck & Co Inc
      • 10.4.1 Merck & Co Inc Company Details
      • 10.4.2 Company Description and Business Overview
      • 10.4.3 Sales, Revenue and Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
      • 10.4.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
      • 10.4.5 Merck & Co Inc Recent Development
    • 10.5 Tesaro
      • 10.5.1 Tesaro Company Details
      • 10.5.2 Company Description and Business Overview
      • 10.5.3 Sales, Revenue and Market Share of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs
      • 10.5.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Product Introduction
      • 10.5.5 Tesaro Recent Development

    11 Value Chain and Sales Channels Analysis

    • 11.1 Value Chain Analysis
    • 11.2 Sales Channels Analysis
      • 11.2.1 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Channels
      • 11.2.2 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Distributors
    • 11.3 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Customers

    12 Market Forecast

    • 12.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales and Revenue Forecast 2019-2025
    • 12.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Type
    • 12.3 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Application
    • 12.4 Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Forecast by Regions
      • 12.4.1 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Sales Forecast by Regions 2019-2025
      • 12.4.2 Global Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Revenue Forecast by Regions 2019-2025
    • 12.5 United States Market Forecast
    • 12.6 European Union Market Forecast
    • 12.7 China Market Forecast
    • 12.8 Rest of World
      • 12.8.1 Japan
      • 12.8.2 Korea
      • 12.8.3 India

    13 Research Findings and Conclusion

      14 Appendix

      • 14.1 Research Methodology
        • 14.1.1 Methodology/Research Approach
          • 14.1.1.1 Research Programs/Design
          • 14.1.1.2 Market Size Estimation
          • 14.1.1.3 Market Breakdown and Data Triangulation
        • 14.1.2 Data Source
          • 14.1.2.1 Secondary Sources
          • 14.1.2.2 Primary Sources
      • 14.2 Author Details

      Summary:
      Get latest Market Research Reports on Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs. Industry analysis & Market Report on Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs is a syndicated market report, published as Global (United States, European Union and China) Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs Market Research Report 2019-2025. It is complete Research Study and Industry Analysis of Chemotheraphy Induced Nausea and Vomiting (CINV) Drugs market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.

      Last updated on

      REPORT YOU MIGHT BE INTERESTED

      Purchase this Report

      $3,280.00
      $4,920.00
      $6,560.00
      2,568.24
      3,852.36
      5,136.48
      3,017.60
      4,526.40
      6,035.20
      515,091.20
      772,636.80
      1,030,182.40
      272,863.20
      409,294.80
      545,726.40
      Credit card Logo

      Related Reports


      Reason to Buy

      Request for Sample of this report